Skip to main content
AAN.com
Articles
June 1, 2009

Population-based study of risk and predictors of stroke in the first few hours after a TIA

June 2, 2009 issue
72 (22) 1941-1947

Abstract

Background: Several recent guidelines recommend assessment of patients with TIA within 24 hours, but it is uncertain how many recurrent strokes occur within 24 hours. It is also unclear whether the ABCD2 risk score reliably identifies recurrences in the first few hours.
Methods: In a prospective, population-based incidence study of TIA and stroke with complete follow-up (Oxford Vascular Study), we determined the 6-, 12-, and 24-hour risks of recurrent stroke, defined as new neurologic symptoms of sudden onset after initial recovery.
Results: Of 1,247 first TIA or strokes, 35 had recurrent strokes within 24 hours, all in the same arterial territory. The initial event had recovered prior to the recurrent stroke (i.e., was a TIA) in 25 cases. The 6-, 12-, and 24-hour stroke risks after 488 first TIAs were 1.2% (95% confidence interval [CI]: 0.2–2.2), 2.1% (0.8–3.2), and 5.1% (3.1–7.1), with 42% of all strokes during the 30 days after a first TIA occurring within the first 24 hours. The 12- and 24-hour risks were strongly related to ABCD2 score (p = 0.02 and p = 0.0003). Sixteen (64%) of the 25 cases sought urgent medical attention prior to the recurrent stroke, but none received antiplatelet treatment acutely.
Conclusion: That about half of all recurrent strokes during the 7 days after a TIA occur in the first 24 hours highlights the need for emergency assessment. That the ABCD2 score is reliable in the hyperacute phase shows that appropriately triaged emergency assessment and treatment are feasible.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (chandratheva.pdf)

REFERENCES

1.
Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000;284:2901–2906.
2.
Coull AJ, Lovett JK, Rothwell PM. Population based study of early risk of stroke after transient ischemic attack or minor stroke: implications for public education and organisation of services. BMJ 2004;328:326.
3.
Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischemic attack. Lancet 2007;369:283–292.
4.
Giles MF, Rothwell PM. Risk of stroke early after transient ischemic attack: a systematic review and meta-analysis. Lancet Neurol 2007;6:1063–1072.
5.
Giles MF, Rothwell PM. Substantial underestimation of the need for outpatient services for TIA and minor stroke. Age Ageing 2007;36:676–680.
6.
Kleindorfer D, Panagos P, Pancioli A, et al. Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke 2005;36:720–723.
7.
Rothwell PM, Warlow CP. Timing of TIAs preceding stroke: time window for prevention is very short. Neurology 2005;64:817–820.
8.
Department of Health. National Stroke Strategy (2007). Available at: dh.gov.uk/stroke. Accessed 2008 Dec. 10.
9.
Guidelines for management of ischemic stroke and transient ischemic attack 2008. Cerebrovasc Dis 2008;25:457–507.
10.
National Institute for Health and Clinical Excellence TIA and Stroke Guidelines (2008). Available at: www.nice.org.uk. Accessed 2008 Dec. 10.
11.
Royal College of Physicians Intercollegiate Stroke Working Party. Clinical Effectiveness and Evaluation Unit. National Clinical Guideline for Stroke,
12.
Johnston SC, Nguyen-Huynh MN, Schwarz ME, et al. National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol 2006;60:301–313.
13.
Rothwell PM, Giles MF, Flossmann E, et al. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischemic attack. Lancet 2005;366:29–36.
14.
Rothwell PM, Coull AJ, Giles MF, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004;363:1925–1933.
15.
Rothwell PM, Coull AJ, Silver LE, et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005;366:1773–1783.
16.
Coull AJ, Silver LE, Bull LM, Giles MF, Rothwell PM. Direct assessment of completeness of ascertainment in a stroke incidence study. Stroke 2004;35:2041–2045.
17.
Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35–41.
18.
Rothwell PM, Giles MF, Chandratheva A, et al. Effect of urgent treatment of transient ischemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 2007;370:1432–1442.
19.
Coull AJ, Rothwell PM. Underestimation of the early risk of recurrent stroke: evidence of the need for a standard definition. Stroke 2004;35:1925–1929.
20.
Bray JE, Coughlan K, Bladin C. Can the ABCD Score be dichotomised to identify high-risk patients with transient ischemic attack in the emergency department? Emerg Med J 2007;24:92–95.
21.
Correia M, Silva MR, Magalhaes R, Guimaraes L, Silva MC. Transient ischemic attacks in rural and urban northern Portugal: incidence and short-term prognosis. Stroke 2006;37:50–55.
22.
Cucchiara BL, Messe SR, Taylor RA, et al. Is the ABCD score useful for risk stratification of patients with acute transient ischemic attack? Stroke 2006;37:1710–1714.
23.
Hill MD, Yiannakoulias N, Jeerakathil T, Tu JV, Svenson LW, Schopflocher DP. The high risk of stroke immediately after transient ischemic attack: a population-based study. Neurology 2004;62:2015–2020.
24.
Lavallee PC, Meseguer E, Abboud H, et al. A transient ischemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol 2007;6:953–960.
25.
Lisabeth LD, Ireland JK, Risser JM, et al. Stroke risk after transient ischemic attack in a population-based setting. Stroke 2004;35:1842–1846.
26.
Purroy F, Montaner J, Rovira A, Delgado P, Quintana M, Alvarez-Sabin J. Higher risk of further vascular events among transient ischemic attack patients with diffusion-weighted imaging acute ischemic lesions. Stroke 2004;35:2313–2319.
27.
Tsivgoulis G, Spengos K, Manta P, et al. Validation of the ABCD score in identifying individuals at high early risk of stroke after a transient ischemic attack: a hospital-based case series study. Stroke 2006;37:2892–2897.
28.
Calvet D, Lamy C, Touze E, Oppenheim C, Meder JF, Mas JL. Management and outcome of patients with transient ischemic attack admitted to a stroke unit. Cerebrovasc Dis 2007;24:80–85.
29.
Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004;364:331–337.
30.
Markus HS, Droste DW, Kaps M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005;111:2233–2240.
31.
Payne DA, Jones CI, Hayes PD, et al. Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation 2004;109:1476–1481.
32.
Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuck AM, Buchan AM. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomized controlled pilot trial. Lancet Neurol 2007;6(11):961–969.
33.
Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706–1717.
34.
Bowry AD, Brookhart MA, Choudhry NK. Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events. Am J Cardiol 2008;101:960–966.

Information & Authors

Information

Published In

Neurology®
Volume 72Number 22June 2, 2009
Pages: 1941-1947
PubMed: 19487652

Publication History

Published online: June 1, 2009
Published in print: June 2, 2009

Permissions

Request permissions for this article.

Notes

Authors

Affiliations & Disclosures

A. Chandratheva, MRCP
From the Stroke Prevention Research Unit, Oxford University Department of Clinical Neurology, UK.
Z. Mehta, DPhil
From the Stroke Prevention Research Unit, Oxford University Department of Clinical Neurology, UK.
O. C. Geraghty, MRCP
From the Stroke Prevention Research Unit, Oxford University Department of Clinical Neurology, UK.
L. Marquardt, MD
From the Stroke Prevention Research Unit, Oxford University Department of Clinical Neurology, UK.
P. M. Rothwell, MD, PhD, FRCP, FMedSci
From the Stroke Prevention Research Unit, Oxford University Department of Clinical Neurology, UK.
On behalf of the Oxford Vascular Study
From the Stroke Prevention Research Unit, Oxford University Department of Clinical Neurology, UK.

Notes

Address correspondence and reprint requests to Prof. Peter M. Rothwell, Stroke Prevention Research Unit, Oxford University Department of Clinical Neurology, Level 6, West Wing, John Radcliffe Hospital, OX3 9DU, UK [email protected].

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Safety of Antithrombotic Therapy within 24 Hours after Recombinant Tissue-Plasminogen Activator Treatment for Large-Artery Atherosclerosis Stroke: Insights from Emergent PTA/CAS Cases, Journal of Nippon Medical School, 91, 3, (307-315), (2024).https://doi.org/10.1272/jnms.JNMS.2024_91-309
    Crossref
  2. Biochemical, biomechanical and imaging biomarkers of ischemic stroke: Time for integrative thinking, European Journal of Neuroscience, 59, 7, (1789-1818), (2024).https://doi.org/10.1111/ejn.16245
    Crossref
  3. H-FABP as a Biomarker in Transient Ischemic Attack, Journal of Cardiovascular Translational Research, (2024).https://doi.org/10.1007/s12265-024-10552-4
    Crossref
  4. Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome, Transient Ischemic Attack, and Noncardioembolic Stroke in an Era of Cost Containment, Journal of Investigative Medicine, 60, 5, (792-800), (2023).https://doi.org/10.2310/JIM.0b013e31824e9a50
    Crossref
  5. Biomarkers in Hypertension and Hypertension-related Disorders, Current Medicinal Chemistry, 30, 34, (3846-3879), (2023).https://doi.org/10.2174/0929867329666220921113403
    Crossref
  6. Prevención secundaria de ictus, FMC - Formación Médica Continuada en Atención Primaria, 30, 9, (476-482), (2023).https://doi.org/10.1016/j.fmc.2023.03.012
    Crossref
  7. Endovascular Therapy of Extracranial and Intracranial Occlusive Disease, Stroke, (959-969.e2), (2022).https://doi.org/10.1016/B978-0-323-69424-7.00066-1
    Crossref
  8. Evaluation of Transient Ischemic Attack and Minor Stroke: A Rapid Outpatient Model for the COVID-19 Pandemic and Beyond, The Neurohospitalist, 12, 1, (38-47), (2021).https://doi.org/10.1177/19418744211000508
    Crossref
  9. Short-term outcomes of Chinese transient ischaemic attack patients in an Emergency department in Hong Kong: Result of management with an agreed protocol with neurologists, Hong Kong Journal of Emergency Medicine, 30, 6, (349-357), (2021).https://doi.org/10.1177/10249079211004319
    Crossref
  10. Evaluating the use of gradient echo imaging for the detection of cerebral microbleeds in acute stroke cases: A retrospective data analysis in a UK stroke unit, Radiography, 27, 2, (561-567), (2021).https://doi.org/10.1016/j.radi.2020.11.015
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share